Addison Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56K | Hold |
200
| – | – | ﹤0.01% | 729 |
|
|
2025
Q1 | $3.56K | Hold |
200
| – | – | ﹤0.01% | 705 |
|
|
2024
Q4 | $5.96K | Hold |
200
| – | – | ﹤0.01% | 645 |
|
|
2024
Q3 | $3.13K | Hold |
200
| – | – | ﹤0.01% | 708 |
|
|
2024
Q2 | $3.43K | Hold |
200
| – | – | ﹤0.01% | 665 |
|
|
2024
Q1 | $3.13K | Hold |
200
| – | – | ﹤0.01% | 602 |
|
|
2023
Q4 | $2.99K | Hold |
200
| – | – | ﹤0.01% | 602 |
|
|
2023
Q3 | $3.23K | Hold |
200
| – | – | ﹤0.01% | 566 |
|
|
2023
Q2 | $8.3K | Hold |
200
| – | – | ﹤0.01% | 494 |
|
|
2023
Q1 | $12K | Hold |
200
| – | – | 0.01% | 443 |
|
|
2022
Q4 | $14.7K | Hold |
200
| – | – | 0.01% | 406 |
|
|
2022
Q3 | $15K | Hold |
200
| – | – | 0.01% | 392 |
|
|
2022
Q2 | $14K | Hold |
200
| – | – | 0.01% | 404 |
|
|
2022
Q1 | $17K | Buy |
+200
| New | +$17K | 0.01% | 416 |
|